Press Release
Press Release
The U.S. Food and Drug Administration (FDA) has approved Moderna's mFlusiva, the first mRNA-based vaccine for influenza, for individuals aged 50 and older. This new vaccine has shown higher effectiveness in clinical trials compared to traditional…
Read Full Story
Press Release
Press Release
Press Release
Press Release
Press Release
Press Release
Business
Press Release
Press Release
Press Release
Press Release